In order to evaluate whether QC can affect the expressions of death receptors other than DR4 and DR5, we have taken multiple breast cancer cells (MCF-10A-Tr, MDA-MB-231, MCF-7, BT-20, MDA-MB-175, and ZR-75-1), kidney cancer (HEK-293T), and colon cancer cells (HCT-116) along with normal breast cells MCF-10A and treated with different concentrations of QC. Here, TNFRSF10A is linked to kidney cancer.